Indiana University School of Medicine;Indiana University;IU ;Iu School Of Medicine;alzheimer disease;Alzheimer

Dr. Liana Apostolova is available to comment on new results of a phase III clinical trial of Donanemab, an Alzheimer’s disease medication for patients with early symptoms of the disease.

[ad_1] Liana Apostolova, MD is the associate dean of Alzheimer’s disease research at Indiana University School of Medicine. Dr. Apostolova…